GENE ONLINE|News &
Opinion
Blog

Editors' Picks
Denmark: The Country Behind Ozempic Is Preparing for Life After the GLP-1 Windfall
2026-06-10
Eight Phase 3 Trials, 29 Phase 2 Readouts, and a Diversifying Pipeline: Eyes on Alzheimer’s in 2026
2026-06-02
Two Approved Drugs, Hundreds of Trials, and a New Target: Alzheimer’s at a Turning Point
2026-06-02
GSK Bolsters Oncology Portfolio With $10.6 Billion Nuvalent Acquisition in its Third Major Deal in 2026
On June 9, 2026, GSK announced a definitive agreement to acquire Nuvalent, a Boston-based clinical-stage biopharma company specialized in creating precisely targeted oncology therapies. The …

Home Read More »

2026-06-09
Uncovering How Cellular Waste Buildup in the Brain Drives Aging and Neurodegenerative Diseases
2026-06-08
Advanced Biologics & Biosimilars
EirGenix Leverages Dual Engines of CDMO and Biosimilars to Capitalize on Global Biopharma Supply Chain Realignment
As geopolitical tensions, the U.S. Biosecure Act, and reshoring initiatives reshape global pharmaceutical manufacturing, Taiwan-based EirGenix is positioning itself at the intersection of CDMO growth …

EirGenix Leverages Dual Engines of CDMO and Biosimilars to Capitalize on Global Biopharma Supply Chain Realignment Read More »

2026-06-11
HanchorBio Presents Next Generation Tri-specific Biologics and Manufacturing Strategies at Biologics World Taiwan 2026
Industry leaders gathered in Biologics World Taiwan 2026 to explore new biopharmaceutical developments and manufacturing strategies. HanchorBio Founder and CEO Dr. Scott Liu and Chemistry …

HanchorBio Presents Next Generation Tri-specific Biologics and Manufacturing Strategies at Biologics World Taiwan 2026 Read More »

2026-05-14
The Next Decade in Cancer Therapeutics: How Immunotherapy is Evolving from Efficacy to Precision
Amid a rapidly aging global population, coupled with changes in lifestyle and the accumulation of environmental risk factors, cancer incidence rates are continuously surging. According …

The Next Decade in Cancer Therapeutics: How Immunotherapy is Evolving from Efficacy to Precision Read More »

2026-05-05
LATEST
EirGenix Leverages Dual Engines of CDMO and Biosimilars to Capitalize on Global Biopharma Supply Chain Realignment
2026-06-11
nVent Electric Appoints New Chief Strategy and Revenue Officers
2026-06-10
Snail Games Announces Bellwright Console Launch and New ARK Content at IGN Live 2026
2026-06-10
BJJLink Launches AI-Powered Platform for Martial Arts Gym Member Acquisition
2026-06-10
Trump Media and TAE Technologies Provide Merger Status Update on June 10, 2026
2026-06-10
OZOP Energy Solutions Partners with Tenace Consulting for Southern California Distribution
2026-06-10
Agassi Sports Entertainment Signs Darren Cahill to Lead Global Coaching and Technology Initiatives
2026-06-10
Markets & Deals
AI-Powered Blood Test Accurately Classifies Multiple Neurodegenerative Diseases And Detects Co-Existing Conditions
2026-06-06
The Island That Builds AI: Inside NVIDIA GTC Taipei and How Taiwan Became the World’s Most Critical Technology Ecosystem
2026-06-01
The Computer Was Built for Humans. At GTC Taipei, Jensen Huang Just Built One for AI
2026-06-01
Breakthrough RNA Segment Editing Technology Offers New Hope for Treating Neurodegenerative Diseases
2026-06-05
German Rare Disease Diagnostics Firm CENTOGENE Moves Closer to Asia’s Frontlines With Taiwan HQ
2026-05-22
From Bench to BLA: Why Japan’s Ryuichi Morishita Believes AI Could Fix Gene Therapy’s Cost Crisis
2026-05-21
EirGenix Leverages Dual Engines of CDMO and Biosimilars to Capitalize on Global Biopharma Supply Chain Realignment
2026-06-11
Navigating the Translational Future of Cancer Care with ASCO 2026 Late-Breaking Abstracts
2026-06-02
Eight Phase 3 Trials, 29 Phase 2 Readouts, and a Diversifying Pipeline: Eyes on Alzheimer’s in 2026
2026-06-02
Ranking & Reports
5 FDA First-in-Class Approvals in 2026: New Mechanisms, New Modalities, New Markets
2026-05-21
Hantavirus Outbreak Sparks Market Jitters, but Investors See Little Chance of Another COVID-Style Meltdown
2026-05-13
Global Cancer Research Output Reveals Bipolar Institutional Dominance and Emerging Market Opportunities
2026-04-30
VIDEOS
Categories
EirGenix Leverages Dual Engines of CDMO and Biosimilars to Capitalize on Global Biopharma Supply Chain Realignment
2026-06-11
SynbioTech Redefines Probiotics With a Research-Driven CDMO Platform
2026-06-02
From Crisis to Blueprint: How Australian Burns Pioneer Fiona Wood Is Engineering the Future of Scarless Healing
2026-05-25
GSK Bolsters Oncology Portfolio With $10.6 Billion Nuvalent Acquisition in its Third Major Deal in 2026
2026-06-09
Protuoso Biosciences Launches with $9.5M to Pioneer AI-Driven “Hub-and-Spoke” Biologics Development
2026-05-27
CapitaLand Unveils S$1.4 Billion Geneo Hub, Marking a Chapter for Singapore Science Park
2026-05-22
5 FDA First-in-Class Approvals in 2026: New Mechanisms, New Modalities, New Markets
2026-05-21
J&J’s First-Ever MDD Analysis Highlights Growing Focus on Remission, Weight Gain, and Recovery
2026-05-13
From Prostate Cancer to Oncology: Has the Real-World Evidence Era Arrived?
2026-05-08
Japan Advances Clinical Translation of Extracellular Vesicle Therapies Through GMP-Grade EV Programs
2026-05-25
CapitaLand Unveils S$1.4 Billion Geneo Hub, Marking a Chapter for Singapore Science Park
2026-05-22
German Rare Disease Diagnostics Firm CENTOGENE Moves Closer to Asia’s Frontlines With Taiwan HQ
2026-05-22
Pandorum Partners With Nucelion to Scale Exosome-Based Eye Therapies Across Asia-Pacific
2026-01-08
Taiwan’s Biotech Bet: DCB’s Role in Advancing Exosome Therapy
2025-05-22
A Closer Look at EV-Based Therapeutics: Purification, Scalability, and GMP Compatibility
2025-05-06
Can Global Healthcare Systems Stay Resilient Without Reinventing Pharmaceutical Manufacturing?
2026-05-20
Hong Kong Turns Healthcare Into Industrial Strategy at ASGH 2026
2026-05-11
EirGenix Advances into CPHI Japan, Capitalizing on Market Trends to Deepen Its Strategic Footprint in Japan
2026-04-28
Why Rare Disease Drugmakers Are Building Regional Strategies Instead of Global Ones
2026-06-01
Protuoso Biosciences Launches with $9.5M to Pioneer AI-Driven “Hub-and-Spoke” Biologics Development
2026-05-27
From Crisis to Blueprint: How Australian Burns Pioneer Fiona Wood Is Engineering the Future of Scarless Healing
2026-05-25
Cruise Ship Hantavirus Outbreak Revives COVID-19 Era Fears as WHO Says Public Risk Remains Low
2026-05-13
Nipah Virus Resurgence in South Asia: Health Authorities Ramp Up Surveillance Amid Fresh Outbreak Fears
2026-01-29
Viral Defense 2.0: How Long-Acting Biologics and Startups are Reimagining the Flu Season
2026-01-20
Uncovering How Cellular Waste Buildup in the Brain Drives Aging and Neurodegenerative Diseases
2026-06-08
Breakthrough or Bubble? The High-Stakes 2026 Readouts for Psychedelic Giants
2026-01-27
When Machines Listen: The Promise and Peril of AI in Mental Health
2025-10-14
Scroll to Top